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Creation of optogenetic switches for specific activation of cell
death pathways can provide insights into apoptosis and could
also form a basis for noninvasive, next-generation therapeutic
strategies. Previous work has demonstrated that cryptochrome
2 (Cry2)/cryptochrome-interacting  helix–loop– helix (CIB),
a blue light–activated protein–protein dimerization module
from the plant Arabidopsis thaliana, together with BCL2-asso-
ciated X apoptosis regulator (BAX), an outer mitochondrial
membrane–targeting pro-apoptotic protein, can be used for
light-mediated initiation of mitochondrial outer membrane
permeabilization (MOMP) and downstream apoptosis. In this
work, we further developed the original light-activated Cry2-
BAX system (hereafter referred to as OptoBAX) by improving
the photophysical properties and light-independent interac-
tions of this optogenetic switch. The resulting optogenetic con-
structs significantly reduced the frequency of light exposure
required for membrane permeabilization activation and also
decreased dark-state cytotoxicity. We used OptoBAX in a series
of experiments in Neuro-2a and HEK293T cells to measure the
timing of the dramatic morphological and biochemical changes
occurring in cells after light-induced MOMP. In these experi-
ments, we used OptoBAX in tandem with fluorescent reporters
to image key events in early apoptosis, including membrane
inversion, caspase cleavage, and actin redistribution. We then
used these data to construct a timeline of biochemical and mor-
phological events in early apoptosis, demonstrating a direct link
between MOMP-induced redistribution of actin and apoptosis
progression. In summary, we created a next-generation Cry2/
CIB–BAX system requiring less frequent light stimulation and
established a timeline of critical apoptotic events, providing
detailed insights into key steps in early apoptosis.
Among the wide-ranging applications of optogenetic pro-
teins, which include light-mediated control of transcription (1),
ion channels (2), and enzymatic activity (3), the use of light for
wholesale activation or inhibition of cell signaling pathways is a
uniquely powerful approach to determination of cell fate, acting
as a rapid noninvasive trigger for cascades of biochemical
events that ultimately decide whether a cell proliferates or dies.
After many years of effort, numerous cell signaling pathways
critical for cell fate decisions have been elucidated, including
pathways for the control of cell division (4), cell motility (5), and
apoptosis (6). As a result, it is possible to identify individual
proteins that serve as highly specific effector biomolecules for
the initiation of signaling cascades undergirding these vital pro-
cesses. Such effector molecules are ideal candidates for incor-
poration into light-activated protein switches for control of cell
signaling pathways (7–9). These switches are useful not only for
study of the effector molecules themselves but also of biochem-
ical events that occur in the wake of their activation. In the case
of apoptosis, which can be viewed as a singular destination
(“cell death”) attainable by various routes (10), numerous effec-
tor molecules exist that could serve as candidates for optical
control of apoptosis, including the Bcl-2 family of proteins (11).
BAX, a 21-kDa protein that is a key effector of mitochondrial
membrane permeabilization (MOMP)21 in the intrinsic apopto-
sis pathway, is one such effector molecule with an in vivo activ-
ity profile that makes it ideal for incorporation into an optoge-
netic switch: phosphorylation-gated activity, predominantly
cytosolic localization in the “off” state, and robust initiation
of permeabilization of the outer mitochondrial membrane
(OMM) (12–15). Prior work has demonstrated that incorpora-
tion of BAX into a cryptochrome 2 (Cry2)– cryptochrome-in-
teracting  helix–loop– helix (CIB)– based optogenetic switch
enables light-activated MOMP and release of apoptotic effector
proteins such as Smac-1 (16). A key step in the engineering of
this switch was the implementation of a phosphomimetic
mutation in the BAX C terminus at serine 184 (S184E), which
maintains BAX in a predominantly cytosolic state by increasing
the off rate of localization at the OMM, eliminating one poten-
tial source of light-independent background (17). However,
another potential source of light-independent (or “dark”) back-
ground for this optogenetic switch is the dark-state interaction
of the Cry2 photoreceptor with the mitochondrial Tom20 –CIB
construct. In this work, we created next-generation iterations
of the Cry2–CIB BAX system (OptoBAX), hereafter referred to
as “OptoBAX 2.0”. The optimized versions of this cell death
switch include longer Cry2 variants designed to reduce the
Funding was provided by the East Carolina University Division of Research,
Economic Development and Engagement, Thomas Harriot College of Arts
and Sciences, and the Department of Chemistry. The authors declare that
they have no conflicts of interest with the contents of this article.
This article contains Figs. S1–S5 and Movies S1–S3.
1 To whom correspondence should be addressed. Tel.: 252-328-9730; E-mail:
hughesr16@ecu.edu.
2 The abbreviations used are: MOMP, mitochondrial outer membrane
permeabilization; OMM, outer mitochondrial membrane; BAX, BCL2-asso-
ciated X apoptosis regulator; CIB, cryptochrome-interacting  helix–
loop– helix; Z-VAD(OMe)-fmk, benzyloxycarbonyl-VAD(OMe)-fluorom-
ethyl ketone; PS, phosphatidylserine; STS, staurosporine; TBS, Tris-buffered
saline; CTCF, corrected total cell fluorescence; LED, light emitting diode;
Pen-Strep, Penicillin-Streptomycin; DPBS, Dulbecco’s phosphate buffered
saline.
croARTICLE
16918 J. Biol. Chem. (2019) 294(45) 16918 –16929

























dark-state interaction with CIB and incorporate a mutation
that extends the photocycle of the Cry2–CIB interaction, pro-
moting longer association times with the OMM (18). This opti-
mized construct requires less frequent light stimulation to
maintain OptoBAX and the OMM, an advantage for long-time
course experiments where blue light toxicity may be of concern
(19). In addition, although the initial studies with OptoBAX
were conducted in HeLa cells, this study applied the OptoBAX
2.0 system to the Neuro-2a and HEK293T cell lines, demon-
strating light-initiated apoptosis in these cell lines analogous to
that observed previously in HeLa cells. Finally, in HEK293T
cells, a combination of fluorescently tagged proteins and com-
mercially available dyes are used for multicolor monitoring of
critical steps in apoptosis downstream of the initial mitochon-
drial insult (cytoskeletal rearrangement, chromatin condensa-
tion, membrane inversion, and caspase cleavage) and compared
with results observed previously with a classic small-molecule
initiator of the apoptotic cascade. The resulting data are used to
create a timeline of key apoptotic events in HEK293T cells and
provide insight into changes in actin localization and degrada-
tion of the nuclear/cytoplasmic barrier, both key steps in early
apoptosis.
Results and discussion
Creation and validation of new optogenetic constructs
Initial versions of the OptoBAX system were comprised of
BAX as a fusion to the N terminus of a Cry2PHR (1– 498)–
mCherry (BAX.Cry2PHR.mCh) fusion protein or as a fusion
to the C terminus of a Cry2PHR (1– 498)–mCherry fusion
(Cry2PHR.mCh.BAX) in tandem with the Cry2-interacting
partner CIB in fusion with a Tom20 OMM localization domain
with or without a C-terminal GFP (Tom20.CIB.GFP or
Tom20.CIB) (20). Although both BAX fusions have been dem-
onstrated to initiate light-mediated apoptosis in HeLa cells, the
C-terminal fusion of a BAX mutant (S184E) has been demon-
strated to be a more effective light-activated apoptotic switch
due to reduced association of BAX with the OMM because of
the phosphomimic S184E and faster induction of the apoptotic
cascade versus the N-terminal BAX construct (1 h (C-termi-
nal) versus 2–3 h (N-terminal)) (16). Furthermore, in the initial
study, although the C-terminal BAX construct could be
recruited irreversibly to the OMM after 50 min of repeated
illumination, the N-terminal construct, after the same duration
and pattern of illumination, still reverted to the cytosol, identi-
fying the exposed C terminus of BAX as necessary for efficient
induction of apoptosis. However, despite its higher efficacy,
light-independent cell death was a significant drawback associ-
ated with the C-terminal construct over the N-terminal con-
struct (22% (C-terminal) versus 9% (N-terminal) 48 h post-
transfection in HeLa cells, as assessed by trypan blue assay (16)).
Taken together, these results implicate dark-state association
between Cry2 and CIB in tandem with an exposed C terminus
of BAX as the source of undesirable levels of background cell
death. To improve these initial constructs, we sought to create
an OptoBAX with reduced levels of light-independent cell
death and retention of light-dependent pro-apoptotic efficacy.
Recently, optimized versions of the Cry2 optogenetic system
have been reported, demonstrating, in the context of a yeast
two-hybrid assay, that extending the truncated Cry2PHR from
498 to 515 amino acids or longer (up to 535 amino acids) sig-
nificantly reduced the light-independent background present
in the optogenetic system (18). In the same report, a genetic
screen also identified a Cry2 mutant (L348F) that extends the
photocycle of Cry2 well beyond that of the WT protein, pro-
longing the half-life of the light-promoted Cry2–CIB interac-
tion from 6 min to 24 min (18). This mutation prolongs the
lifetime of the light-promoted semiquinone form of FAD, the
light-responsive Cry2 cofactor. We hypothesized that incorpo-
rating similar changes into OptoBAX might result in an
improved pro-apoptotic switch via reduced light-independent
Cry2–CIB interaction and, with incorporation of the L348F
mutant, reduced light input compared with the original Opto-
BAX, creating a system more easily amenable to incorporation
into drug discovery platforms or model organisms. As a result,
for the OptoBAX 2.0 system, two additional Cry2–BAX fusions
were assembled: Cry2(1–531).mCh.BAX.S184E and Cry2(1–
531).L348F.mCh.BAX.S184E, pairing them with the original
Tom20.CIB.GFP and Tom20.CIB constructs (Fig. 1A). Assays
of light-independent cell death (“dark background”) were sub-
sequently performed in dually transfected HeLa cells using a
fluorescent indicator of cell viability (Fig. S1). Compared
with the original OptoBAX system, the OptoBAX 2.0 system
reduced dark background from 36% (Cry2PHR.mCh.
BAX.S184E) to 20% (Cry2(1–531).mCh.BAX.S184E and
Cry2(1–531).L348F.mCh.BAX.S184E), similar to the back-
ground cell death observed with the Cry2.mCh fusions without
BAX. The effect of the L348F mutant on the Cry2.mCh fusions
was further validated in HeLa cells, utilizing a single pulse of
470-nm light to promote association of Cry2 with the
OMM-localized CIB domain (Fig. 1, B and C, and Movie S1),
confirming that the L348F mutant extended the half-life of
association with the OMM from 6.25 (0.5) min to 32.8 (1.0)
min. The Cry2(1–531).L348F.mCh.BAX.S184E construct was
also assayed for its ability to induce apoptosis versus the
Cry2(1–531).L348F.mCh fusion (Fig. 2A and Movie S2). We
subsequently investigated whether the L348F mutant induces
apoptosis with less frequent light stimulation versus the non-
mutant Cry2(1–531).mCh.BAX.S184E (Fig. 2B). An experi-
ment using an interval of 10 min between blue light pulses,
which is longer than the half-life of the WT construct but sig-
nificantly shorter than that of the extended photocycle mutant,
was designed to demonstrate the result of less frequent light
stimulation in the extended photocycle construct. As a result
of this illumination sequence, the nonmutant Cry2 construct
repeatedly reverted to the cytosolic state during the experi-
ment, whereas the L348F mutant maintained consistent local-
ization at the OMM. The results of this experiment were
assessed by manually counting the number of apoptotic cells
(based on the loss of adherent cell morphology) after 1 h of
simultaneous blue light stimulation and imaging on a Leica
Dmi8 wide-field fluorescence microscope. In this study, 65%
(21%) of transfected cells expressing the Cry2(1–531).
L348F.mCh.BAX.S184E/Tom20.CIB.GFP fusion became apo-
ptotic versus 12% of transfected cells (13%) expressing the
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standard photocycle Cry2(1–531).mCh.BAX.S184E construct,
demonstrating that prolonging the photocycle enables more
apoptosis with less frequent light input (percent cell collapse
and standard deviations determined from 10 replicate measure-
ments). In addition, some background apoptosis was observed
with the fusions without BAX (Cry2(1–531).L348F.mCh and
Cry2(1–531).mCh; 6% (7%) and 4% (5%), respectively,
determined from 10 replicate measurements). This back-
ground is attributed to the loss of mitochondrial integrity and
subsequent apoptotic entry because of repeated recruitment of
protein fusions to the OMM. To confirm that the observed
background was a result of apoptosis, we conducted identical
illumination experiments in the presence of 50 M Z-VA-
D(OMe)-fmk. In the presence of this irreversible caspase inhib-
itor, no background apoptosis was observed for the Cry2
fusions, and OptoBAX-dependent apoptosis was completely
inhibited (Fig. 2B, inset; eight replicates per protein fusion). It
should be noted that these experiments analyzed apoptotic
entry of transfected cells that were fully adherent at the begin-
ning of the illumination time course; a measure of overall cell
viability in the absence of light stimulation is shown in Fig. S1.
Overall, the HeLa cell studies indicate that OptoBAX 2.0
constructs possess two key improvements over the original
OptoBAX system: lower dark background and enhanced pho-
tocontrol. The lowering of dark background relative to the ini-
tially reported system is particularly important for the biologi-
cal experiments in this paper. In the system reported
previously, the higher levels of dark background present predis-
posed cells to rapid apoptotic entry upon light activation (15
min until cellular collapse for the Cry2PHR.BAX.S184E con-
struct (16)). In contrast, in our system, lower levels of dark
background and, hence, later apoptotic entry upon light
activation (40 min until cellular collapse for the
Cry2PHR.BAX.S184E construct in HeLa cells (Movie S2)
provide an extended time window suitable for more detailed
dissection of the biochemical events occurring prior to, dur-
ing, and after cellular collapse.
Translation to other cell lines
Given the common mechanism of BAX-mediated MOMP
and subsequent apoptosis in mammalian cells (21), it was antic-
ipated that this optogenetic system might readily translate to
other mammalian cell lines. To test this assumption, the Opto-
BAX 2.0 constructs were deployed in two additional cell lines,
Neuro-2a and HEK293T (Fig. 2C). Induction of apoptosis upon
recruitment of Cry2(1–531).L348F.mCh.BAX.S184E to the
OMM with light was observed in both cell lines. In particular,
the reliably high transfection efficiency observed with the
HEK293T cell line made further exploration of the apoptotic
cascade in this cell line particularly appealing. Furthermore,
in contrast to HeLa cells, no background cellular collapse
was observed in 1-h light activation experiments conducted
with Bax-free protein fusions (Cry2(1–531).L348F.mCh and
Cry2(1–531).mCh; 0 of 180 and 0 of 167 total cells counted
from six replicates) in the HEK293T cell line. As a result, the
remainder of the experiments in this work were carried out in
the HEK293T cell line.
Tracking the hallmarks of apoptosis with optogenetic
techniques
The morphological and biochemical hallmarks of apoptosis
include cell blebbing, loss of adhesion and cellular volume,
chromatin condensation and nuclear fragmentation, cytoskel-
etal rearrangement, phosphatidylserine inversion, release of
mitochondrial proteins (cytochrome c/Smac/Diablo), and
caspase cleavage (22). Fluorescently labeled proteins and small
molecules for tracking these key apoptotic events have become
widely available in recent years (23–26). This makes practical
the prospect of using a light-activated system for induction of
apoptosis in conjunction with live-cell– compatible markers on
a multichannel fluorescence microscope equipped with a live-
cell incubator. To this end, several markers for key apoptotic
events were selected for inclusion in multicolor imaging exper-
iments, including a nuclear stain (Hoechst 33342) for monitor-
ing chromatin condensation, a marker of phosphatidylserine
(PS) inversion (Annexin V-FITC and Annexin V-Cy5), a cyto-
skeletal marker (GFP-actin (27)), and a marker for downstream
caspase cleavage (CellEvent caspase 3/7). Our first experiment
sought to simultaneously monitor chromatin condensation,
cytoskeletal rearrangement, and phosphatidylserine inversion
in the wake of BAX translocation to the OMM. The HEK293T
cell line demonstrated efficient transfection of both compo-
nents of the OptoBAX 2.0 system (Cry2(1–531).L348F.
mCh.BAX.S184E and Tom20.CIB) in addition to a third pro-
tein, a cytoskeletal marker for actin (GFP-actin). In the same
experiment, chromatin was labeled with Hoechst 33342, and an
Annexin V-Cy5 fusion was incorporated as a marker for PS
inversion. These additional components provided a four-color
system for monitoring light-induced BAX translocation to the
mitochondria (mCherry/TxRed), cytoskeletal rearrangement
(FITC/GFP), chromatin condensation (4,6-diamidino-2-phe-
nylindole), and membrane flipping (Cy5). Using this system,
the impact of BAX-mediated apoptosis on the cytoskeleton and
chromatin was measured over the course of a 2-h illumination
experiment (Fig. 3 and Movie S3). In the course of the multi-
color imaging experiment, the following changes were
observed: redistribution of the GFP-actin construct, indicative
of cytoskeletal rearrangement; nuclear collapse and intensifica-
tion of the fluorescence intensity of the Hoechst 33342 dye,
indicative of chromatin condensation; and incorporation of the
Annexin V-Cy5 dye, indicative of phosphatidylserine inversion
(Fig. 3A).
Figure 1. Redesign of optogenetic actuators and characterization of the extended photocycle mutant L348F. A, optimized versions of OptoBAX created
for reduction of light-independent cell death and extension of the photocycle. Western blot (-mCherry, inset) lanes: 1, Cry2.531.mCherry; 2,
Cry2.531.L348F.mCherry; 3, Cry2.531.mCherry.BAX; 4, Cry2.531.L348F.mCherry.BAX; 5, Cry2PHR.mCherry.BAX. B, demonstration of the elongated photocycle in
the Cry2 L348F mutant. Images shown are before and 5 and 10 min after activation with a 150-ms pulse of 470-nm light. C, plot of normalized fluorescence data
from the experiment shown in B. Error bars represent standard deviations from six replicate measurements of light-initiated recruitment using the method
described by Haar et al. (53). Scale bar  10 m.
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Figure 2. Minimal light application required for apoptotic cell death and application to other cell lines. A, OMM recruitment of OptoBAX constructs with
(Cry2.531.L348F.BAX/Tom20.CIB.GFP) and without (Cry2.531.L348F/Tom20.CIB.GFP) the pro-apoptotic BAX fusion in HeLa cells. Cells were illuminated with a
150-ms pulse of 470-nm light every 10 min over a 2-h time course. B, quantification of cellular collapse over the 1-h time course experiment. Error bars represent
standard deviations from a minimum of 10 replicate measurements per condition. *, p  0.05 for all pairwise comparisons (one-way analysis of variance).
Inhibition of Cry2.531.L348F.BAX occurs in the presence of 50 M Z-VAD(OMe)-fmk. C, demonstration of light-induced cellular collapse with OptoBAX
(Cry2.531.L348F.BAX/Tom20.Cib.GFP) in HEK293T and Neuro-2a cell lines over a 2-h time course (470 nm, 150-ms pulse; images were acquired every minute).
Scale bars  10 m.
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Significant redistribution of the GFP-Actin marker from the
cytosol to both the nucleus and the mitochondria occurred in
the wake of OptoBAX activation, with 44% of cells (111 of 252)
clearly demonstrating mitochondrial GFP-actin 70 min post-
activation (Fig. 3, B and C). The accumulation of actin and
numerous actin-binding proteins (cofilin 1, CAP1) at the OMM
in the wake of small-molecule-induced apoptosis is often char-
acterized as an early event that occurs well prior to BAX trans-
location (28 –30). In our system, however, membrane permea-
bilization with OptoBAX precipitates downstream actin
redistribution to the OMM well after BAX recruitment (30
min post-OptoBAX activation). Although the accumulation of
actin at mitochondria remains a poorly understood event in the
BAX-mediated apoptosis pathway (28, 30–32), this result
points to a closer relationship between cytoskeletal dynamics,
Bcl-2 family translocation events, and apoptotic progression
than described previously (31).
Inhibition of actin dynamics
The multicolor OptoBAX experiments were repeated in the
presence of compounds known to have opposing effects on
actin dynamics: jasplakinolide, which inhibits actin depolymer-
ization, maintaining the F-actin state, and latrunculin A, which
inhibits actin polymerization by sequestering G-actin (33). As
expected, treatment of cells with these compounds resulted in
strikingly different distributions of our actin-GFP reporter (Fig.
S2). However, despite the differences in actin distribution,
treatment with either compound delayed the entry of cells into
light-activated apoptosis compared with the no-treatment con-
trol, as assessed by both the reduction of chromatin condensa-
tion and PS externalization during a 2-h time course (percent
condensed nuclei 70 min post-OptoBAX activation: jasplakino-
lide, 12% (2%) condensed nuclei (14 of 115 total cells); Latrun-
culin A, 5% (1%) condensed nuclei (8 of 148 total cells);
untreated cells, 55% (2%) condensed nuclei (54 of 98 total
cells); Fig. S2; assessed from three replicate measurements).
Although the redistribution of actin to mitochondria occurred
as described previously in untreated cells, the same event was
infrequently observed with the jasplakinolide-treated (3%
(1%), 3 of 115 total cells) and Latrunculin A–treated (1%
(0.02%), 2 of 148 total cells) populations post-OptoBAX acti-
vation. It should be noted that, although these compounds
delayed apoptotic onset in our system, both compounds have
been demonstrated to be pro-apoptotic in cell culture over long
incubation periods, precluding lengthier experiments (34 –36).
Nonetheless, it is clear that perturbations of actin dynamics
delay key components of our light-activated apoptotic cascade.
Furthermore, the observed correlation between BAX-induced
MOMP and actin rearrangement may not be entirely causal. It
is possible that the rapid mitochondrial depolarization induced
by small-molecule-initiated apoptosis (i.e. staurosporine (STS))
triggers events that lead to actin redistribution in advance of
endogenous BAX translocation. For example, in previous stud-
ies of STS-induced apoptosis, mitochondrial depolarization
occurred rapidly after treatment, whereas BAX maximally
translocated to the OMM several hours post-STS treatment
(37, 38). As a result, in our system, it cannot be ruled out that
BAX-dependent mitochondrial depolarization drives actin
redistribution via a partially MOMP-independent mechanism.
Nuclear accumulation of actin
In addition to actin redistribution, nuclear accumulation of
GFP-actin was also observed in the wake of OptoBAX activa-
tion, occurring just after the appearance of mitochondrial GFP-
actin (Fig. 3C). The transition of cytosolic actin to nuclear actin
has been described previously and may be part of a general
cellular stress response (39, 40). The question of whether this
freshly nuclear localized actin binds to chromatin may also have
interesting implications for actin’s role in the repression or acti-
vation of transcription of genes vital for completing the apopto-
tic cascade in mammalian cells, reinforcing the notion of actin
as an important part of the apoptotic transcriptome, as previ-
ously observed in yeast (41–44). Furthermore, redistribution of
cytoskeletal actin into the nucleus may also provide insight into
the timing of disruption of the nuclear– cytoplasmic barrier, a
key apoptotic event that precipitates many of the later events in
apoptosis by providing access of cytoplasmic proteins to the
nuclear compartment (45–47). Interestingly, both increasing
chromatin condensation (Fig. 3D) and increasing phosphati-
dylserine inversion (Fig. 3E) occur in tandem with nuclear accu-
mulation of actin. Both chromatin condensation and phos-
phatidylserine inversion peaked 70 –90 min after OptoBAX
activation.
Caspase 3/7 cleavage
In our final multicolor experiment, a fluorescent indicator
of caspase cleavage was used to assess caspase 3/7 cleavage
downstream of OptoBAX activation (Fig. 4A). Caspase activ-
ity was observed within 1 h of BAX recruitment and
increased steadily thereafter (Fig. 4B). Although this event
begins relatively early, it peaks later (2 h post-BAX recruit-
ment), consistent with previous Western blot assessment of
caspase cleavage in the OptoBAX system (16). In contrast,
control experiments utilizing Cry2(1–531).L348F.mCh and
Tom20.CIB did not activate the caspase activity indicator
dye or the marker for phosphatidylserine inversion within
the same time period of recruitment to the OMM and imag-
ing (Fig. S3). Furthermore, experiments with OptoBAX in
the presence of 50 M Z-VAD(OMe)-fmk showed significant
suppression of caspase activity (Fig. 4B). Interestingly,
although chromatin condensation was observed during our
Figure 3. Four-color experiment. A, multicolor imaging (Leica DmI8 wide-field microscope equipped with an OKOLab stage-top incubator) of mitochondrial
recruitment, chromatin condensation, actin rearrangement, and phosphatidylserine exposure in HEK293T cells. B, overlay of actin/mitochondria after 2 h of
imaging. C, time lapse of actin rearrangement and accumulation at mitochondria. D and E, percent chromatin condensation versus time for the chromatin
marker (Hoechst 33342) (D) and fluorescence intensity changes for the PS marker (Annexin V-Cy5) (E). Images were acquired every minute over a 2-h time
course. Error bars represent standard deviations from four replicate measurements (Fig. 3D) and six replicate measurements (Fig. 3E) per condition. Scale bars 
10 m.
Hallmarks of apoptosis via optogenetic actuators

























experiments, significant nuclear fragmentation was not
observed during the same timeframe (1% of cells over a
120-min time course), suggesting that, like peak caspase
cleavage, nuclear fragmentation occurs later in BAX-medi-
ated apoptosis. As a corollary to these results, longer time
course experiments in HeLa cells utilizing a programmable
light emitting diode (LED) device for cellular illumination,
followed by nuclear staining and immunostaining, demon-
strated nuclear fragmentation 7 h post-apoptosis induc-
tion (Figs. S4 and S5).
A timeline of apoptotic events
One potentially useful application of the OptoBAX system,
in conjunction with the aforementioned markers, is establish-
ment of a timeline of key apoptotic events to define not only the
order but also the interplay between key steps in the apoptotic
cascade. In turn, establishment of a timeline around a specific
event (i.e. BAX translocation to the OMM) may provide novel
insights into their interdependence. Utilizing data from our
multicolor imaging experiments, a timeline of these early apo-
Figure 4. Three-color experiment. A, multicolor imaging (Leica DmI8 wide-field microscope equipped with an OKOLab stage-top incubator) of mitochondrial
recruitment, chromatin condensation, and caspase cleavage in HEK293T cells. B, fluorescence intensity versus time for the caspase activity marker (CellEvent
3/7). Images were acquired every minute over a 2.5-h time course. Cells were either treated with 50 M Z-VAD-fmk (dark circles) or left untreated (empty circles)
for 50 min prior to the experiment. Error bars represent standard deviations from four replicate measurements. Scale bar  10 m.
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ptotic events relative to OptoBAX activation was assembled
(Scheme 1). This timeline demonstrates that much happens
within the first 2 h of the apoptotic cascade, with certain events
appearing to be synchronized. For example, the actin cytoskel-
eton, long implicated as a key player in apoptotic progression,
undergoes redistribution from the cytosol to the mitochondria
in addition to movement from the cytosol to the nucleus. This
redistribution event generally precedes phosphatidylserine
inversion. It is possible that wholesale redistribution of actin, a
key structural component of the cytoskeleton, contributes to
membrane instability and subsequent inversion. Interestingly,
the increase in accumulation of Annexin V is also concurrent
with an increase in chromatin condensation. These events
(chromatin condensation and Annexin V accumulation) occur
within the same timeframe as actin redistribution, indicating
collapse and rearrangement of the actin cytoskeleton as a com-
mon thread linking these events in the progression of apoptosis
(31). Finally, previous studies of staurosporine-induced apopto-
sis have reported that actin redistribution to the OMM occurs
well before BAX translocation. In our system, recruitment of
OptoBAX to the OMM precipitates the actin OMM localiza-
tion event. Staurosporine has been shown to affect multiple
apoptotic pathways (intrinsic and extrinsic), which may be the
basis for the timing of the BAX localization event relative to
that of actin. (48) Utilization of an optogenetic system such as
OptoBAX for control of a single event in the apoptotic cascade
may be a more precise way of examining these translocation
events. For example, although previous studies have focused on
defining the pro-apoptotic role of cofilin at the OMM (49), the
universal importance of the role played by cofilin and other
ABPs at the OMM during apoptosis remains a matter of debate
(28). Future studies in our laboratory using these optogenetic
tools will attempt to resolve the complicated web of transloca-
tion events at the OMM occurring in early apoptosis.
Experimental procedures
Cloning
The Cry2(1–531) gene was amplified by PCR (New England
Biolabs Q5 polymerase) from the full-length Cryptochrome-2
gene using a forward primer encoding an XhoI restriction site
with the sequence GGCCAACTCGAGATGAAGATGGACA-
AAAAGAC and a reverse primer encoding an XmaI restriction
site with the sequence TGATATCCCCGGGCTACTTGTTG-
GTCATTAGAAG. The resulting PCR amplicon was then
digested, gel-purified, and ligated into a mCherry-N1 vector
(Clontech) containing BAX S184E as a fusion to the C terminus
of mCherry. Site-directed mutagenesis was used to introduce
the L348F mutation using a forward primer with the sequence
CCGGAATGAGAGAGTTTTGGGCTACCGGATGG and
reverse primer with the sequence CCATCCGGTAGCCCAA-
AACTCTCTCATTCCGG. Cloning methods for constructs
used in prior work (Cry2PHR.mCh.BAX, Tom20.CIB.GFP, and
Tom20.CIB.STOP) have been described elsewhere (16). The
actin-GFP (pCAG-mGFP-actin; Addgene, 21948) construct
was a generous gift from Ryohei Yasuda (27).
Cell culture and transfection
Midi prep quantities of DNA of each construct were then
created from Escherichia coli and collected for cell transfection.
Transfections were then performed with Lipofectamine 3000
reagent (Invitrogen) following the manufacturer’s suggested
protocols. Briefly, for dual transfections in 35-mm glass-bot-
tom dishes, plasmid DNA was combined at a 1:1 ratio (1,250
ng/plasmid) in 125 l of Opti-MEM, followed by addition of 5
l of P3000 reagent. In a separate vial, 3.75 l of Lipofectamine
3000 was added to 125 l of Opti-MEM. The two 125-l solu-
tions were combined and allowed to incubate at room temper-
ature for 10 min, followed by dropwise addition to cell culture.
For triple transfections, plasmid DNA was combined at a 1:1:1
ratio (1,000 ng/plasmid), followed by an identical transfection
procedure. Transfection solutions were allowed to remain on
cells overnight. Cells were maintained at 37 °C and 5% CO2 in a
humidified tissue culture incubator. HeLa and HEK293T cells
were maintained in DMEM supplemented with 10% FBS and
1% Pen-Strep (Penicillin-Streptomycin). Neuro-2a cells were
maintained in minimum Eagle’s medium supplemented with
10% FBS and 1% Pen-Strep.
Cell viability measurements
Background cell death experiments were performed to deter-
mine the cell toxicity of OptoBAX constructs in the absence of
light exposure. Transfections were performed on HeLa cells in
6-well plates and then maintained in complete darkness for 2
days prior to incubation with a cell viability stain (Live-or-Dye
488/515, Biotium). Briefly, cells were washed once with DPBS
containing calcium and magnesium, followed by incubation at
room temperature with the viability stain (diluted 1:1,000 in
DPBS) for 30 min. Afterward, cells were fixed with 4% parafor-
SCHEME 1. Timeline of apoptotic events.
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maldehyde in PBS for 15 min at room temperature, washed
three times with 1 ml of DPBS, and maintained in DPBS for
subsequent imaging. Images of fixed cells were acquired on a
Leica Dmi8 fluorescence microscope.
Application of fluorescent dyes
For the four-color experiment, triple-transfected cells
(Cry2.mCh.BAX/Tom20.CIB/GFP-Actin) in a 35-mm glass-
bottom dish (Mattek) were removed from the incubator, cell
culture medium was removed by pipette, and cells were gently
washed once with DPBS supplemented with calcium and mag-
nesium. 1 ml of PBS containing Hoechst 33342 was then
applied to the cells, which were returned to the incubator for 10
min. After the elapsed time, the medium was removed, and cells
were washed with DPBS (2  1 ml). A prewarmed buffer con-
taining DPBS supplemented with 10% FBS and Annexin V-Cy5
(10 l/1 ml of buffer; Thermo Fisher, A23204) was added to
the cells, which were promptly placed on the microscope for
initiation of the light-activated experiment. For the three-
color experiment, dually transfected cells (Cry2.mCh.BAX/
Tom20.CIB.STOP) were removed from the incubator, cell cul-
ture medium was removed by pipette, and cells were gently
washed once with DPBS supplemented with calcium and mag-
nesium. 1 ml of PBS containing Hoechst 33342 was then
applied to the cells, which were returned to the incubator for 10
min. After the elapsed time, the medium was removed, and cells
were washed with DPBS (2  1 ml). A prewarmed buffer con-
taining DPBS supplemented with 10% FBS and CellEvent
Caspase 3/7 Green (1 l/1 ml of buffer; Thermo Fisher,
C10427) was added to the cells, which were promptly placed on
the microscope for initiation of the light-activated experiment.
Cell treatments with actin-binding compounds
Cells were pretreated with actin-binding compounds for 1 h
prior to imaging. Jasplakinolide (Santa Cruz Biotechnology)
was diluted from a 1 mM stock in DMSO to a working concen-
tration of 200 nM in DMEM supplemented with 10% FBS. Prior
to imaging, the cells were incubated with Hoechst 33342 for 10
min, followed by a 1-ml PBS wash. Cells were then resupplied
with medium for live-cell imaging (DPBS/10% FBS/200 nM jas-
plakinolide/Annexin V-Cy5). Latrunculin A (Santa Cruz Bio-
technology) was diluted from a 1 mM stock in DMSO to a work-
ing concentration of 2 M in DMEM supplemented with 10%
FBS. Prior to imaging, the cells were incubated with Hoechst
33342 for 10 min, followed by a 1-ml PBS wash. Cells were then
resupplied with medium for live-cell imaging (DPBS/10%
FBS/2 M Latrunculin A/Annexin V-Cy5).
Cell treatments with caspase inhibitor
Cells were pretreated with the pan-caspase inhibitor Z-VA-
D(OMe)-fmk (Santa Cruz Biotechnology) for 50 min prior to
imaging. The compound was diluted from a 10 mM stock in
DMSO to a working concentration of 50 M in DMEM supple-
mented with 10% FBS. Prior to imaging, the cells were incu-
bated with Hoechst 33342 for 10 min, followed by a 1-ml PBS
wash. Cells were then resupplied with medium for live-cell
imaging (L-15/10% FBS/50 M Z-VAD(OMe)-fmk).
Microscopy
A Leica DMi8 live-cell imaging system equipped with an
OKOLab stage-top live-cell incubation system, LASX software,
Leica HCX PL APO 63/1.40 – 0.60 numerical aperture oil
objective, Lumencor LED light engine, CTRadvanced	 power
supply, and Leica DFC900 GT camera was used to acquire
images. Exposure times were set at 150 ms (GFP, 470 nm), 150
ms (4,6-diamidino-2-phenylindole, 395 nm), 300 ms
(mCherry, 550 nm), and 300 ms (Cy5, 640 nm) with LED light
sources at 50% power, and images were acquired every minute
or every 10 min.
Microscopy data analysis
Analysis of microscopy date was performed in Fiji equipped
with the BioFormats package. Fluorescence intensity measure-
ments were normalized on a scale from 0 –1 prior to being
averaged. Average normalized intensities were computed from
four to six fields of view on a 63 objective, with each field of
view encompassing 100 (10) transfected cells. Mitochondrial
residence time plots were generated by quantifying the change
in fluorescence intensity at the mitochondria over time after
light recruitment. Fluorescence intensity measurements were
normalized and averaged from six mitochondrial clusters per
transfection condition. After normalizing the change in fluo-
rescence over time, the mitochondrial association half-life was
defined as the time for fluorescence intensity of the light-re-
cruited reagent to reach 50% maximum intensity at the mito-
chondria. Image overlays were created using the Merge Chan-
nels function in Fiji.
Western blotting
HeLa cells were lysed post-transfection with 200 l of mam-
malian protein extraction reagent lysis buffer (Thermo Scien-
tific) plus protease inhibitors. After 10 min on a rotary shaker at
room temperature, lysates were collected and centrifuged for
15 min (1,000 rpm at 4 °C), and supernatants were reserved.
The resulting lysates were subjected to electrophoresis on a
10% SDS-PAGE gel and then transferred to PVDF membranes
(20 V overnight at 4 °C). Membranes were then blocked for 1 h
with 5% BSA in TBS with 1% Tween (TBST), followed by incu-
bation with the primary antibody (Rockland anti-mCherry
antibody, 600-401-P16) at 1:1,000 dilution in 5% milk and
TBST overnight at 4 °C on a platform rocker. The membranes
were then washed three times for 5 min each with TBST and
incubated with anti-rabbit IgG HRP secondary antibody
(Abcam, 6721) at 1:3,000 in 5% BSA and TBST for 2 h at room
temperature. After washing three times for 5 min each with
TBST, the membranes were exposed to a chemiluminescent
substrate for 5 min and imaged using an Azure cSeries imaging
station.
Programmable LED device
The device (designed and constructed by Hoffman and
Hughes) combines four wavelength ranges (440 – 460 nm, 520 –
540 nm, 650 – 670 nm, and 720 –750 nm) into a single package
using surface mount technology and is powered with an
Arduino Uno system. Luxeon Rebel and Luxeon Color series
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LEDs were soldered on 20-mm mounts with a hot air gun
designed for surface-mounted devices. The LEDs/metal core
printed circuit board aluminum LED bases were fixed to a
130  70 mm, rectangular, 15-mm-high heat sink to prevent
overheating and allow longer exposure of samples. The inten-
sity of the light was controlled with a combination of variable
resistors, positive-negative-positive transistors, and Zener
diodes. The LED arrays are controlled using an Arduino con-
troller to control illumination, time, intensity, and wavelength.
Light intensity was measured with a Fisherbrand digital light
meter; effects of illumination protocols on medium tempera-
ture were determined with a Fisherbrand digital thermometer
using a type K beaded probe.
Cellular illumination and immunostaining
HeLa cells were plated in 35-mm glass-bottom dishes (Mat-
tek) at a density of 2.0  105 cells/dish and maintained at 37 °C
in a humidity-controlled incubator with a 5% CO2 atmo-
sphere in DMEM (10% FBS and 1% Pen-Strep). The following
day, cells were transfected with Cry2.L348F.531.mCh.BAX and
Tom20.CIB.GFP as reported previously. 24 h after transfection,
cells were illuminated with 440- to 460-nm light using a pro-
grammable LED device prior to being returned to the incuba-
tor. At the conclusion of the dark incubation period, cells were
washed three times with 1 ml of PBS and then fixed with 1 ml of
4% paraformaldehyde in PBS at room temperature for 10 min.
Cells were washed twice with 1 ml of PBS and blocked and
permeabilized for 20 min in antibody dilution buffer (1% BSA,
0.3% Triton X-100, and PBS) at 4 °C. Blocking was followed by
overnight incubation at 4 °C with rabbit anti-cleaved caspase 3
antibody (Cell Signaling, 9661) at 1:400 dilution in antibody
dilution buffer (1% BSA, 0.3% Triton X-100, and PBS). Cells
were then washed with PBS (three times for 5 min) before incu-
bation with anti-rabbit Alexa Fluor 647 secondary antibody
(Life Technologies, A21245) at 1:500 dilution in antibody dilu-
tion buffer. After washing cells with PBS (three times for 5 min),
nuclei were stained briefly (5 min) with Hoechst 33342 (1
g/ml), followed by image acquisition on a confocal micro-
scope (Olympus IX2-DSU tandem spinning disk confocal
microscope, 60 objective).
Corrected total cell fluorescence
Whole-cell fluorescence intensities were measured in Fiji/
ImageJ (50) and quantified using the corrected total cell fluo-
rescence (CTCF) method (51, 52). Briefly, individual cells
were outlined in Fiji, followed by calculation of the area,
integrated density, and mean gray value for each cell. For
each image, background measurements of fluorescence
intensity were taken from regions without cells. The follow-
ing formula was then used to calculate the CTCF for each
cell: CTCF  integrated density 
 (cell area  mean back-
ground fluorescence).
Plasmids
The plasmids generated for this publication are available
through Addgene, Inc., a not-for-profit plasmid DNA
repository.
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